The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

The rate of abdominal surgical interventions and associated postoperative complications in inflammatory bowel disease (IBD) patients is still substantially high. There is an ongoing debate as to whether or not patients who undergo treatment with anti-tumor necrosis factor-alpha (TNF-α) agents may ha...

Full description

Bibliographic Details
Main Authors: Kamacay Cira, Marie-Christin Weber, Dirk Wilhelm, Helmut Friess, Stefan Reischl, Philipp-Alexander Neumann
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
anti-tumor necrosis factor-alpha
colorectal surgery
postoperative complications
Online Access:https://www.mdpi.com/2077-0383/11/23/6884

Similar Items

Similar Items